These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20347563)

  • 1. [Drugs during preeclampsia. Fetal risks and pharmacology].
    Serreau R; ; ; ;
    Ann Fr Anesth Reanim; 2010 Apr; 29(4):e37-46. PubMed ID: 20347563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fate of drugs in pregnancy.
    Mucklow JC
    Clin Obstet Gynaecol; 1986 Jun; 13(2):161-75. PubMed ID: 2873913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicardipine in pre-eclamptic patients: placental transfer and disposition in breast milk.
    Bartels PA; Hanff LM; Mathot RA; Steegers EA; Vulto AG; Visser W
    BJOG; 2007 Feb; 114(2):230-3. PubMed ID: 17166219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of valproic acid in maternal, fetal, and newborn sheep. I: placental transfer, plasma protein binding, and clearance.
    Kumar S; Wong H; Yeung SA; Riggs KW; Abbott FS; Rurak DW
    Drug Metab Dispos; 2000 Jul; 28(7):845-56. PubMed ID: 10859159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia.
    Downing JW; Ramasubramanian R; Johnson RF; Minzter BH; Paschall RL; Sundell HW; Engelhardt B; Lewis R
    Med Hypotheses; 2004; 63(6):1057-64. PubMed ID: 15504576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug disposition and effects in the fetus.
    Rurak DW; Wright MR; Axelson JE
    J Dev Physiol; 1991 Jan; 15(1):33-44. PubMed ID: 1678754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of transplacental clearances and fetal clearance to drug disposition in the ovine maternal-fetal unit.
    Szeto HH; Umans JG; Rubinow SI
    Drug Metab Dispos; 1982; 10(4):382-6. PubMed ID: 6126338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics in pregnancy and placental drug transfer.
    Reynolds F; Knott C
    Oxf Rev Reprod Biol; 1989; 11():389-449. PubMed ID: 2576466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The transfer of drugs into the amniotic fluid].
    Amon I; Amon K
    Zentralbl Gynakol; 1976; 98(16):961-9. PubMed ID: 9756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive drugs in pregnancy.
    Naden RP; Redman CW
    Clin Perinatol; 1985 Oct; 12(3):521-38. PubMed ID: 2865023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of dietary fatty acids during pregnancy on placental, fetal and postnatal development--a review.
    Herrera E
    Placenta; 2002 Apr; 23 Suppl A():S9-19. PubMed ID: 11978055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug effects on embryo and fetus. 2. Diaplacental transport of drugs].
    Reinhardt D; Richter O
    Fortschr Med; 1981 Sep; 99(35):1394-8. PubMed ID: 7274943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental drug transporters and their role in fetal protection.
    Iqbal M; Audette MC; Petropoulos S; Gibb W; Matthews SG
    Placenta; 2012 Mar; 33(3):137-42. PubMed ID: 22265855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of hypertensive diseases in pregnancy--general recommendations and long-term oral therapy].
    Rath W
    Z Geburtshilfe Neonatol; 1997; 201(6):240-6. PubMed ID: 9491543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the magnesium aspartate hydrochloride administration to the maternal circuit on the aspartate concentration of the fetal circuit under in vitro perfusion of human placenta.
    Malek A; Leiser R
    Eur J Obstet Gynecol Reprod Biol; 2009 Jan; 142(1):12-7. PubMed ID: 18951687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of a fat-free diet on the content and synthesis of arachidonic acid in the feto-placental unit of the rat].
    Winkler L; Schellhorn P; Zimmermann T; Goetze E
    Acta Biol Med Ger; 1977; 36(2):221-30. PubMed ID: 906733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing pregnancy centered medications: drugs which do not cross the human placenta.
    Gedeon C; Koren G
    Placenta; 2006 Aug; 27(8):861-8. PubMed ID: 16313957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the placental transfer of cisapride in sheep. Plasma levels in the pregnant ewe, the fetus, and the lamb.
    Veereman-Wauters G; Monbaliu J; Meuldermans W; Woestenborghs R; Verlinden M; Heykants J; Rudolph CD
    Drug Metab Dispos; 1991; 19(1):168-72. PubMed ID: 1673393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problems of pharmacokinetics in pregnancy. A bibliographic review].
    Minora T; Ventresca GP; Mariani L
    Ann Ostet Ginecol Med Perinat; 1990; 111(3):159-73. PubMed ID: 2275511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental transfer and metabolism of betamethasone in human pregnancy.
    Anderson AB; Gennser G; Jeremy JY; Ohrlander S; Sayers L; Turnbull AC
    Obstet Gynecol; 1977 Apr; 49(4):471-4. PubMed ID: 857211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.